Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study
Published Online: 2021-09-?
Journal: The Lancet Infectious Diseases•Publisher: Elsevier BV
Authors: Anne-Laure Chabanon•Bo Fu•Brandon J Essink•Carlos A DiazGranados•Fernanda Tavares-Da-Silva•Guy de Bruyn•Helene Janosczyk•Howard Schwartz•Ian Frank•Jon Smith•Lawrence D Sher•Lode Schuerman•Marguerite Koutsoukos•Matthew G Davis•Matthew I Bonaparte•Michael C Keefer•Murray A Kimmel•Owen Haney•Paul A Goepfert•Roger Masotti•Sanjay Gurunathan•Stephen J Savarino
